OasisLMS

This activity is intended for trainees, fellows, physicians, APPs, nurses, pharmacists and pharmacologists who care for patients with heart failure.

Following this activity, participants will be better able to:

1. Recognize clinical indicators of advanced heart failure and articulate the importance of early identification and timely referral to an advanced heart failure center.
2. Describe the comprehensive evaluation process for advanced heart failure therapies, including identification of clinical red flags and contraindications to mechanical circulatory support and heart transplantation.
3. Explain the criteria and process for heart transplant listing and discuss key surgical considerations for both heart transplantation and durable mechanical circulatory support therapies (e.g., LVADs).

Program Co-Planners:
Scott Lundgren, DO, FHFSA 
Laura Peters, FNP, FHFSA, HF-Cert
Ian Hollis, PharmD

Faculty:
Joy Coles, DNP, APRN, AGACNP-BC, MBA, CCRN
Jordan Hoffman, MD
Melissa Lyle, MD

Welcome and Introductions
Scott Lundgren, DO, FHFSA

Recognizing Advanced HF: What It Is and When to Refer
Melissa Lyle, MD

Components of an Advanced Therapies Evaluation
Joy Coles, DNP, APRN, AGACNP-BC, MBA, CCRN

Surgical Considerations and Postoperative Expectations
Jordan Hoffman, MD

Panel Discussion

Closing Remarks

The Heart Failure Society of America (HFSA) is committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.

Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Standards for Commercial Support.

The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest: 

• Scott Lundgren, DO, FHFSA - Speaker's Bureau: Abbott Laboratories

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for PHarmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Heart Failure Society of America designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America.  This activity is approved for a maximum of 1.0 contact hours.

The Heart Failure Society of America is an accredited provider of continuing pharmacy education (CPE). This event is accredited for up to 1.0 contact hours of knowledge-based CPE.  ACPE Universal Activity Numbers (UAN): JA4008267-0000-25-011-L01-P (live attendance only); JA4008267-0000-25-012-H01-P (on-demand/home study).

The Heart Failure Society of America has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

This activity is approved for 1.0 contact hours (0.10 CEUs) of general continuing education for health care professionals.

Successful completion of this activity includes the completion of the post-course evaluation.